Chris is the head of digital and social strategy for Biosector 2 and the wider inVentiv Health PR group. He has worked exclusively in digital and social health since the early days when pharmaceutical companies were content to dip their toes into the social media waters. Chris has a diverse background of pharmaceutical and healthcare social media, communications and PR experience ranging from Fortune 100 pharmaceutical companies to small biotechs. Not just a strategist, Chris partners with clients to execute full-scale social media or digital projects from the idea phase all the way through launch and beyond, and is passionate about finding creative solutions that fit in this highly regulated environment.
B2 is part of INC Research/inVentiv Health, an industry-changing new company, purpose-built to help the industry achieve a singular goal: Biopharmaceutical Acceleration. The coming together of two dedicated businesses allows us to address new market realities through clinical and commercial sharing expertise, data and insights to meet the needs of global biopharmaceutical companies of all sizes to speed the delivery of therapies to patients worldwide.